Search for: "Mylan Inc."
Results 461 - 480
of 674
Sort by Relevance
|
Sort by Date
24 Jan 2011, 8:19 pm
Most lawsuits are brought against those responsible for Reglan believe that manufacturers did not properly label the container side effects.Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
23 Jan 2011, 10:44 pm
Mylan Labs., Inc. [read post]
16 Jan 2011, 9:48 pm
The manufacturers that filed the appeals case were: Teva Pharmaceutical Industries, Mylan Inc.'s UDL Laboratories and Actavis Inc. [read post]
31 Dec 2010, 3:57 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
31 Dec 2010, 2:46 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
28 Dec 2010, 11:19 am
Reuters reported the DOJ settlement with Mylan Inc for a 2006 lawsuit over illegal Medicare and Medicaid reimbursements to pharmacists and other healthcare providers. [read post]
28 Dec 2010, 10:58 am
USA, Inc. v. [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
17 Dec 2010, 7:47 am
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
14 Dec 2010, 9:29 pm
Mylan... [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
8 Dec 2010, 2:20 am
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]
1 Dec 2010, 12:15 am
Abraxis Bioscience, Inc. v. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
11 Nov 2010, 12:54 pm
Mylan Pharmaceuticals, Inc., 2010 WL 3339274, at *3 (W.D. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
20 Oct 2010, 1:20 pm
Mylan, Inc., 2010 WL 2008797, slip op. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
